Healthcare Businesses for Sale and Investment in New Zealand

Our venture operates a dual-channel revenue model through Shopify D2C and EU-based pharmacy/retail B2B, supported by a 3PL logistics hub in Brno. We serve an expanding base of early adopters across Europe and New Zealand, with a projected year-1 capacity to scale to 15,000 customers through digital acquisition and pharmacy distribution. We operate on a fully compliant, asset-light supply chain model, with the following foundations already in place: EU compliance completed (CPSR/CPNP) Responsible Person (RP) structure established. Unique New Zealand ingredient IP. GMP-certified contract manufacturing partners. Active market preparation and channel development. D2C Shopify and pharmacy/retail B2B distribution. Founder expertise: 20+ years in procurement, supply chain, GMP/ISO implementation, and corporate governance, supported by a Master’s in Business Administration. Our partnerships with award-winning R&D labs enable end-to-end NPD within a high-quality and premium standard production framework. The new product development process has been constrained by the partner’s abrupt withdrawal of funds. Manufacturing & fulfilment: All production is via GMP-certified contract manufacturers. Storage, pick/pack, and fulfilment managed by a 3PL warehouse in Brno, including climate-controlled storage and EU-wide distribution. Highly scalable setup enabling rapid expansion across EU markets without physical infrastructure investment. Scale & clients: 18 active B2B partners across New Zealand, the Czech Republic, and the Netherlands. 5 contract manufacturers (GMP / ISO 22716 certified). Initial B2C launch targeting 5,000–7,000 consumers in the first 12 months through the Shopify Plus EU hub. Revenue model: 70% B2B ingredient supply to EU formulators and private-label brands. 30% B2C sales via e-commerce of clean-label, daily effervescent collagen + antioxidant products. Promoter experience: 20+ years in procurement, manufacturing, and international trade. Prior leadership in supply-chain optimisation and product commercialisation across NZ, EU, and CIS markets. We work with contractors who are specialists in the EU legal framework and with a pharmaceutical-certified facility under the supervision of skilled staff to increase our earnings. Both branches operate under the same legal entity.

New Zealand based company in the process to start a 5-star luxury cruise ship based long-term old age care residence. - The facility will have a global international customer base of over 550 elderly HNWI, VHNWI, and UHNWI full-time residents per ship. - Business has burgeoning growth rate projections, scaleable and global from day one. The niche market is untapped and to secure first-to-market advantages with economic and physical moats for the next 2-7 years. - Several strategic partner MOUs already in place, with the necessary industry business expertise on the board of advisors to ensure the success of the business model. - We will have a bespoke high-end brand which includes beauty salons and multiple life-enhancing programs for our residents. - We have already finalized the ship we wish to buy and waiting for the investment. - Company does not have any liability. - Business is 100% owned by 2 directors who are husband and wife. - Promoter has over 10 years of experience in this field. - Our residence will have a refundable accommodation deposit per luxury stateroom is currently at USD 65,000 per sqm, and the daily rate per resident will be USD 550 per day for services, and an a la carte menu for luxury items, additional medical and hospitality services,